ARTICLE | Clinical News
North American Vaccine regulatory update
October 23, 1995 7:00 AM UTC
The Beltsville, Md., company's partner, Statens Seruminstitut, filed an application for marketing approval in Denmark for a combined diphtheria, tetanus, pertussis (whooping cough) and enhanced inactivated polio (DTaP-IPV) vaccine. The application seeks approval for the vaccine for all primary and booster doses for infants and children. The companies jointly developed the vaccine in Denmark. ...